| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/23/2011 | US20110150879 Specific depletion of cd4+ t cells |
| 06/23/2011 | US20110150878 Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal |
| 06/23/2011 | US20110150877 Ephrin-b receptor protein involved in carcinoma |
| 06/23/2011 | US20110150876 Prognosis and Treatment of Breast Cancer |
| 06/23/2011 | US20110150875 Egf-a domain-mediated modulation of pcks9 for treating lipid disorders |
| 06/23/2011 | US20110150873 Anti-inflammatory compositions and combinations |
| 06/23/2011 | US20110150871 Treatment of an autoimmune disease using il-18 antagonists |
| 06/23/2011 | US20110150870 Fully human anti-human nkg2d monoclonal antibodies |
| 06/23/2011 | US20110150869 Neuroinvasion Inhibitor |
| 06/23/2011 | US20110150867 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 06/23/2011 | US20110150866 Compositions and Methods for Increasing Bone Mineralization |
| 06/23/2011 | US20110150865 Antibodies to lymphotoxin-alpha |
| 06/23/2011 | US20110150861 Sorf constructs and multiple gene expression |
| 06/23/2011 | US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 06/23/2011 | US20110150761 Polypeptides, polynucleotides encoding same, antibodies thereagainst and methods of using same for diagnosing and treating cancer and skeletal disorders |
| 06/23/2011 | US20110150760 PRLR-Specific Antibody and Uses Thereof |
| 06/23/2011 | US20110150759 Monoclonal antibody 175 tageting the egf receptor and derivatives and uses thereof |
| 06/23/2011 | CA2784498A1 Novel antagonist antibodies and their fab fragments against gpvi and uses thereof |
| 06/23/2011 | CA2784404A1 Antibodies directed against the transferrin receptor and uses thereof for immunotherapy of iron-dependent tumours |
| 06/23/2011 | CA2784278A1 Wash solution and method for affinity chromatography |
| 06/23/2011 | CA2784093A1 Wise binding agents and epitopes |
| 06/23/2011 | CA2781725A1 Methods of treating interstitial cystitis |
| 06/22/2011 | EP2336368A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/22/2011 | EP2336337A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
| 06/22/2011 | EP2336326A2 Method for isolation of soluble polypeptides |
| 06/22/2011 | EP2336323A2 Method for isolation of soluble polypeptides |
| 06/22/2011 | EP2336322A1 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 06/22/2011 | EP2336321A1 Ox2 receptor homolog |
| 06/22/2011 | EP2336311A1 Anti-tuna vasa antibody |
| 06/22/2011 | EP2336190A2 Anti-VEGF antibodies |
| 06/22/2011 | EP2336189A1 Prostate cancer diagnosis and treatment |
| 06/22/2011 | EP2336188A1 Novel antagonist antibodies and their Fab fragments against GPVI and uses thereof |
| 06/22/2011 | EP2336187A2 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
| 06/22/2011 | EP2336186A1 Humanized antibodies against ICAM-1, their production and uses |
| 06/22/2011 | EP2336185A1 Anti- alpha v beta 6 antibodies |
| 06/22/2011 | EP2336184A2 Administration of agents for the treatment of inflammation |
| 06/22/2011 | EP2336183A2 Antibodies against CCR5 and uses thereof |
| 06/22/2011 | EP2336182A1 Treatment of TNF alpha related disorders |
| 06/22/2011 | EP2336181A1 Antibody molecules having specificity for human IL-6 |
| 06/22/2011 | EP2336180A1 Antibody specifically binding to angiopoietin-2 and use thereof |
| 06/22/2011 | EP2336179A1 Stabilized single domain antibodies |
| 06/22/2011 | EP2336178A1 Methods and compositions for inhibiting C-Met dimerization and activation |
| 06/22/2011 | EP2336177A1 Antibodies to DKK-1 |
| 06/22/2011 | EP2336176A1 Antibodies directed against hepatitis c virus e1e2 complex, and their epitopes |
| 06/22/2011 | EP2336175A1 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 06/22/2011 | EP2336174A2 Human monoclonal antibodies against Hendra and Nipah viruses |
| 06/22/2011 | EP2336173A1 Antibody capable of binding to envelope protein 2 of hepatitis c virus, and method for identifying genotype of hepatitis c virus using same |
| 06/22/2011 | EP2336172A1 Removal of high molecular weight aggregates using hydroxyapatite chromatography |
| 06/22/2011 | EP2336170A2 Recombinant triplex scaffold-based polypeptides |
| 06/22/2011 | EP2336168A1 Novel protein and method for producing the protein |
| 06/22/2011 | EP2336161A2 Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use thereof. |
| 06/22/2011 | EP2336160A2 Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use thereof. |
| 06/22/2011 | EP2336159A2 Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use thereof. |
| 06/22/2011 | EP2336157A2 Gene products which are differentially expressed in tumours and use thereof |
| 06/22/2011 | EP2336156A2 Gene products which are differentially expressed in tumours and use thereof |
| 06/22/2011 | EP2336153A1 Improved expression systems with SEC-system secretion |
| 06/22/2011 | EP2336151A1 Replikin peptides and uses thereof |
| 06/22/2011 | EP2336150A2 Replikin peptides and uses thereof |
| 06/22/2011 | EP2336149A1 Protein purification method |
| 06/22/2011 | EP2335732A2 Multiple-variable dose regimen for treating TNF-alpha-related disorders |
| 06/22/2011 | EP2335731A2 Multiple-variable dose regimen for treating TNF-alpha-related disorders |
| 06/22/2011 | EP2335729A2 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 06/22/2011 | EP2335728A1 Specific binding proteins and uses thereof |
| 06/22/2011 | EP2335727A2 Combination treatment for non-hematologic malignancies using an anti-IGF-1R antibody |
| 06/22/2011 | EP2335726A1 Fusion molecules and methods for treatment of immune diseases |
| 06/22/2011 | EP2335073A2 In vivo biofilm infection diagnosis and treatment |
| 06/22/2011 | EP2335069A2 A method of detecting antibodies and antibody-hiv virion complexes |
| 06/22/2011 | EP2335068A1 Method for identifying and selecting drug candidates for combinatorial drug products |
| 06/22/2011 | EP2334706A1 Identification of a conserved inner core oligosaccharide region of moraxella catarrhalis lipopolysaccharide as a vaccine antigen |
| 06/22/2011 | EP2334705A1 Biological products |
| 06/22/2011 | EP2334704A1 Monoclonal antibodies specific for pancreatic neoplasia cells |
| 06/22/2011 | EP2334703A1 Compositions and methods for detecting tlr3 |
| 06/22/2011 | EP2334702A2 Methods for inhibiting ocular angiogenesis |
| 06/22/2011 | EP2334701A2 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof |
| 06/22/2011 | EP2334700A2 Dengue virus neutralizing antibodies and uses thereof |
| 06/22/2011 | EP2334331A1 Anti-notch2 antibodies and methods of use |
| 06/22/2011 | EP2334330A2 Anti-cd147 antibodies, methods, and uses |
| 06/22/2011 | EP2132228B1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| 06/22/2011 | EP1836226B1 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 06/22/2011 | EP1642132B1 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 06/22/2011 | EP1613349B1 Immunogenic recombinant antibody |
| 06/22/2011 | EP1412752B1 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 06/22/2011 | EP1360207B1 Protein arrays of camelid heavy-chain immunoglobulin variable domains |
| 06/22/2011 | EP1328545B1 Human gene critical to fertility |
| 06/22/2011 | EP1204683B1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 06/22/2011 | CN201873667U Screening chip containing transgenic cell specimens |
| 06/22/2011 | CN1891714B Ligand for herpes simplex virus entry mediator and methods of use |
| 06/22/2011 | CN1739029B Prion protein ligands and methods of use |
| 06/22/2011 | CN1244896B Non-M, non-O, HIV-1 strains, fragments and applications |
| 06/22/2011 | CN102105791A Novel monoclonal antibodies against HPV proteins |
| 06/22/2011 | CN102105492A Impaired wound healing compositions and treatments |
| 06/22/2011 | CN102105491A Interleukin-21 receptor binding proteins |
| 06/22/2011 | CN102103141A Immunity-chromatography kit for rapid diagnosis of malaria and its pathogen species and preparation method thereof |
| 06/22/2011 | CN102101887A Monoclonal antibody, immune fluorescence method and kit for detecting puccinia striiformis f.sp.tritici, puccinia triticina f.sp.tritici and puccicinia graminis f.sp.tritici |
| 06/22/2011 | CN101538266B Rogridone hapten, artificial antigen and antibody as well as preparation method and application thereof |
| 06/22/2011 | CN101044247B Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 06/21/2011 | US7964767 Transgenic mice expressing baculovirus soluble GP64 and methods of using such mice to make antibodies |
| 06/21/2011 | US7964713 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
| 06/21/2011 | US7964711 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same |
| 06/21/2011 | US7964707 Anti-IL2 antibodies |